On Tuesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) opened lower -0.72% from the last session, before settling in for the closing price of $2.79. Price fluctuations for IOVA have ranged from $1.64 to $8.15 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 4.17% over the last five years. Company’s average yearly earnings per share was noted 15.83% at the time writing. With a float of $338.65 million, this company’s outstanding shares have now reached $385.46 million.
Iovance Biotherapeutics Inc (IOVA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Iovance Biotherapeutics Inc is 14.69%, while institutional ownership is 47.07%. The most recent insider transaction that took place on Jun 05 ’25, was worth 55,200. In this transaction Chief Commercial Officer of this company bought 30,000 shares at a rate of $1.84, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 23 ’25, when Company’s Chief Regulatory Officer bought 5,600 for $1.74, making the entire transaction worth $9,743. This insider now owns 206,852 shares in total.
Iovance Biotherapeutics Inc (IOVA) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.26 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.27) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.62% during the next five years compared to 4.17% growth over the previous five years of trading.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Trading Performance Indicators
Check out the current performance indicators for Iovance Biotherapeutics Inc (IOVA). In the past quarter, the stock posted a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.20, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Iovance Biotherapeutics Inc (IOVA)
Analysing the last 5-days average volume posted by the [Iovance Biotherapeutics Inc, IOVA], we can find that recorded value of 9.14 million was lower than the volume posted last year of 13.55 million. As of the previous 9 days, the stock’s Stochastic %D was 77.50%.
During the past 100 days, Iovance Biotherapeutics Inc’s (IOVA) raw stochastic average was set at 82.11%, which indicates a significant increase from 75.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.33, while its 200-day Moving Average is $2.45. Now, the first resistance to watch is $2.86. This is followed by the second major resistance level at $2.94. The third major resistance level sits at $3.00. If the price goes on to break the first support level at $2.71, it is likely to go to the next support level at $2.65. Should the price break the second support level, the third support level stands at $2.57.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Key Stats
There are currently 396,968K shares outstanding in the company with a market cap of 1.10 billion. Presently, the company’s annual sales total 164,070 K according to its annual income of -372,180 K. Last quarter, the company’s sales amounted to 67,460 K and its income totaled -91,250 K.
